Breast  ||| S:0 E:7 ||| JJ
cancer  ||| S:7 E:14 ||| NN
in  ||| S:14 E:17 ||| IN
Mexico ||| S:17 E:23 ||| NNP
:  ||| S:23 E:25 ||| :
an  ||| S:25 E:28 ||| DT
urgent  ||| S:28 E:35 ||| JJ
priority  ||| S:35 E:44 ||| NN
Breast  ||| S:44 E:51 ||| NNP
cancer  ||| S:51 E:58 ||| NN
is  ||| S:58 E:61 ||| VBZ
a  ||| S:61 E:63 ||| DT
serious  ||| S:63 E:71 ||| JJ
threat  ||| S:71 E:78 ||| NN
to  ||| S:78 E:81 ||| TO
the  ||| S:81 E:85 ||| DT
health  ||| S:85 E:92 ||| NN
of  ||| S:92 E:95 ||| IN
women  ||| S:95 E:101 ||| NNS
globally  ||| S:101 E:110 ||| RB
and  ||| S:110 E:114 ||| CC
an  ||| S:114 E:117 ||| DT
unrecognized  ||| S:117 E:130 ||| JJ
priority  ||| S:130 E:139 ||| NN
in  ||| S:139 E:142 ||| IN
middle-income  ||| S:142 E:156 ||| JJ
countries ||| S:156 E:165 ||| NNS
.  ||| S:165 E:167 ||| .
This  ||| S:167 E:172 ||| DT
paper  ||| S:172 E:178 ||| NN
presents  ||| S:178 E:187 ||| VBZ
data  ||| S:187 E:192 ||| NNS
from  ||| S:192 E:197 ||| IN
Mexico ||| S:197 E:203 ||| NNP
.  ||| S:203 E:205 ||| .
It  ||| S:205 E:208 ||| PRP
shows  ||| S:208 E:214 ||| VBZ
that  ||| S:214 E:219 ||| DT
breast  ||| S:219 E:226 ||| NN
cancer  ||| S:226 E:233 ||| NN
accounts  ||| S:233 E:242 ||| NNS
for  ||| S:242 E:246 ||| IN
more  ||| S:246 E:251 ||| JJR
deaths  ||| S:251 E:258 ||| NNS
than  ||| S:258 E:263 ||| IN
cervical  ||| S:263 E:272 ||| JJ
cancer  ||| S:272 E:279 ||| NN
since  ||| S:279 E:285 ||| IN
2006 ||| S:285 E:289 ||| CD
.  ||| S:289 E:291 ||| .
It  ||| S:291 E:294 ||| PRP
is  ||| S:294 E:297 ||| VBZ
the  ||| S:297 E:301 ||| DT
second  ||| S:301 E:308 ||| JJ
cause  ||| S:308 E:314 ||| NN
of  ||| S:314 E:317 ||| IN
death  ||| S:317 E:323 ||| NN
among  ||| S:323 E:329 ||| IN
women  ||| S:329 E:335 ||| NNS
aged  ||| S:335 E:340 ||| VBN
30  ||| S:340 E:343 ||| CD
to  ||| S:343 E:346 ||| TO
54  ||| S:346 E:349 ||| CD
and  ||| S:349 E:353 ||| CC
affects  ||| S:353 E:361 ||| VBZ
all  ||| S:361 E:365 ||| DT
socioeconomic  ||| S:365 E:379 ||| JJ
groups ||| S:379 E:385 ||| NNS
.  ||| S:385 E:387 ||| .
Data  ||| S:387 E:392 ||| NNS
on  ||| S:392 E:395 ||| IN
detection ||| S:395 E:404 ||| NN
,  ||| S:404 E:406 ||| ,
although  ||| S:406 E:415 ||| IN
underreported ||| S:415 E:428 ||| NN
,  ||| S:428 E:430 ||| ,
show  ||| S:430 E:435 ||| VBP
6000  ||| S:435 E:440 ||| CD
new  ||| S:440 E:444 ||| JJ
cases  ||| S:444 E:450 ||| NNS
in  ||| S:450 E:453 ||| IN
1990  ||| S:453 E:458 ||| CD
and  ||| S:458 E:462 ||| CC
a  ||| S:462 E:464 ||| DT
projected  ||| S:464 E:474 ||| JJ
increase  ||| S:474 E:483 ||| NN
to  ||| S:483 E:486 ||| TO
over  ||| S:486 E:491 ||| IN
16500  ||| S:491 E:497 ||| CD
per  ||| S:497 E:501 ||| IN
year  ||| S:501 E:506 ||| NN
by  ||| S:506 E:509 ||| IN
2020 ||| S:509 E:513 ||| CD
.  ||| S:513 E:515 ||| .
Further ||| S:515 E:522 ||| RB
,  ||| S:522 E:524 ||| ,
the  ||| S:524 E:528 ||| DT
majority  ||| S:528 E:537 ||| NN
of  ||| S:537 E:540 ||| IN
cases  ||| S:540 E:546 ||| NNS
are  ||| S:546 E:550 ||| VBP
self-detected  ||| S:550 E:564 ||| JJ
and  ||| S:564 E:568 ||| CC
only  ||| S:568 E:573 ||| RB
10 ||| S:573 E:575 ||| CD
%  ||| S:575 E:577 ||| NN
of  ||| S:577 E:580 ||| IN
all  ||| S:580 E:584 ||| DT
cases  ||| S:584 E:590 ||| NNS
are  ||| S:590 E:594 ||| VBP
detected  ||| S:594 E:603 ||| VBN
in  ||| S:603 E:606 ||| IN
stage  ||| S:606 E:612 ||| NN
I.  ||| S:612 E:615 ||| NNP
Mexico  ||| S:615 E:622 ||| NNP
s  ||| S:622 E:624 ||| VBZ
social  ||| S:624 E:631 ||| JJ
security  ||| S:631 E:640 ||| NN
systems  ||| S:640 E:648 ||| NNS
cover  ||| S:648 E:654 ||| VBP
approximately  ||| S:654 E:668 ||| RB
40  ||| S:668 E:671 ||| CD
to  ||| S:671 E:674 ||| TO
45 ||| S:674 E:676 ||| CD
%  ||| S:676 E:678 ||| NN
of  ||| S:678 E:681 ||| IN
the  ||| S:681 E:685 ||| DT
population  ||| S:685 E:696 ||| NN
and  ||| S:696 E:700 ||| CC
include  ||| S:700 E:708 ||| VBP
breast  ||| S:708 E:715 ||| JJ
cancer  ||| S:715 E:722 ||| NN
treatments ||| S:722 E:732 ||| NNS
.  ||| S:732 E:734 ||| .
Since  ||| S:734 E:740 ||| IN
2007  ||| S:740 E:745 ||| CD
the  ||| S:745 E:749 ||| DT
rest  ||| S:749 E:754 ||| NN
of  ||| S:754 E:757 ||| IN
the  ||| S:757 E:761 ||| DT
population  ||| S:761 E:772 ||| NN
has  ||| S:772 E:776 ||| VBZ
had  ||| S:776 E:780 ||| VBN
the  ||| S:780 E:784 ||| DT
right  ||| S:784 E:790 ||| NN
to  ||| S:790 E:793 ||| TO
breast  ||| S:793 E:800 ||| VB
cancer  ||| S:800 E:807 ||| NN
treatment  ||| S:807 E:817 ||| NN
through  ||| S:817 E:825 ||| IN
Seguro  ||| S:825 E:832 ||| NNP
Popular ||| S:832 E:839 ||| NNP
.  ||| S:839 E:841 ||| .
Despite  ||| S:841 E:849 ||| IN
these  ||| S:849 E:855 ||| DT
entitlements ||| S:855 E:867 ||| NN
,  ||| S:867 E:869 ||| ,
services  ||| S:869 E:878 ||| NNS
are  ||| S:878 E:882 ||| VBP
lacking  ||| S:882 E:890 ||| VBG
and  ||| S:890 E:894 ||| CC
interventions  ||| S:894 E:908 ||| NNS
for  ||| S:908 E:912 ||| IN
early  ||| S:912 E:918 ||| JJ
detection ||| S:918 E:927 ||| NN
,  ||| S:927 E:929 ||| ,
particularly  ||| S:929 E:942 ||| RB
mammography ||| S:942 E:953 ||| JJ
,  ||| S:953 E:955 ||| ,
are  ||| S:955 E:959 ||| VBP
very  ||| S:959 E:964 ||| RB
limited ||| S:964 E:971 ||| VBN
.  ||| S:971 E:973 ||| .
As  ||| S:973 E:976 ||| RB
of  ||| S:976 E:979 ||| IN
2006  ||| S:979 E:984 ||| CD
only  ||| S:984 E:989 ||| RB
22 ||| S:989 E:991 ||| CD
%  ||| S:991 E:993 ||| NN
of  ||| S:993 E:996 ||| IN
women  ||| S:996 E:1002 ||| NNS
aged  ||| S:1002 E:1007 ||| VBN
40  ||| S:1007 E:1010 ||| CD
to  ||| S:1010 E:1013 ||| TO
69  ||| S:1013 E:1016 ||| CD
reported  ||| S:1016 E:1025 ||| VBD
having  ||| S:1025 E:1032 ||| VBG
a  ||| S:1032 E:1034 ||| DT
mammography  ||| S:1034 E:1046 ||| NN
in  ||| S:1046 E:1049 ||| IN
the  ||| S:1049 E:1053 ||| DT
past  ||| S:1053 E:1058 ||| JJ
year ||| S:1058 E:1062 ||| NN
.  ||| S:1062 E:1064 ||| .
Barriers  ||| S:1064 E:1073 ||| NNS
exist  ||| S:1073 E:1079 ||| VBP
on  ||| S:1079 E:1082 ||| IN
both  ||| S:1082 E:1087 ||| PDT
the  ||| S:1087 E:1091 ||| DT
demand  ||| S:1091 E:1098 ||| NN
and  ||| S:1098 E:1102 ||| CC
supply  ||| S:1102 E:1109 ||| NN
sides ||| S:1109 E:1114 ||| NNS
.  ||| S:1114 E:1116 ||| .
Lobbying ||| S:1116 E:1124 ||| NNP
,  ||| S:1124 E:1126 ||| ,
education ||| S:1126 E:1135 ||| NN
,  ||| S:1135 E:1137 ||| ,
awareness  ||| S:1137 E:1147 ||| NN
building  ||| S:1147 E:1156 ||| NN
and  ||| S:1156 E:1160 ||| CC
an  ||| S:1160 E:1163 ||| DT
articulated  ||| S:1163 E:1175 ||| JJ
policy  ||| S:1175 E:1182 ||| NN
response  ||| S:1182 E:1191 ||| NN
will  ||| S:1191 E:1196 ||| MD
be  ||| S:1196 E:1199 ||| VB
important  ||| S:1199 E:1209 ||| JJ
to  ||| S:1209 E:1212 ||| TO
ensure  ||| S:1212 E:1219 ||| VB
extended  ||| S:1219 E:1228 ||| VBN
coverage ||| S:1228 E:1236 ||| NN
,  ||| S:1236 E:1238 ||| ,
access  ||| S:1238 E:1245 ||| NN
to  ||| S:1245 E:1248 ||| TO
and  ||| S:1248 E:1252 ||| CC
acceptance  ||| S:1252 E:1263 ||| NN
of  ||| S:1263 E:1266 ||| IN
both  ||| S:1266 E:1271 ||| DT
treatment  ||| S:1271 E:1281 ||| NN
and  ||| S:1281 E:1285 ||| CC
early  ||| S:1285 E:1291 ||| JJ
detection ||| S:1291 E:1300 ||| NN
.  ||| S:1300 E:1302 ||| .
